Key Record Dates
ClinicalTrials.gov Identifier: | NCT00932451 |
---|---|
Brief Title: | An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene |
First Submitted : | June 30, 2009 |
First Submitted that Met QC Criteria : | July 2, 2009 |
First Posted : | July 3, 2009 (Estimate) |
Results First Submitted : | March 14, 2016 |
Results First Submitted that Met QC Criteria : | April 28, 2016 |
Results First Posted : | June 9, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | November 17, 2016 |
Last Update Posted : | January 13, 2017 (Estimate) |